Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CPCB-RPE1 in Advanced Dry AMD
NCT02590692Phase 2Unknown
- Sponsor
- Regenerative Patch Technologies
- Start
- Feb 2016
- Primary completion
- Jul 2019
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of CPCB-RPE1 in geographic atrophy (GA), sponsored by Regenerative Patch Technologies. Status: unknown.
02
Drugs
CPCB-RPE1
03
Conditions
geographic atrophy (GA)
Beyond the preview
Go deeper on NCT02590692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02590692.